Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | May 26, 2026 | May 28, 2026 |
| Bausch Health Companies Inc.BHC · Entity 4363 | Director | March 29, 2024 | April 01, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 94,260 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 15,842 · Balance 94,260 F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.
Bausch Health Companies Inc.
Report date March 29, 2024 · Filed April 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 225,279 |
Reported balance
After 2024-03-29 transaction · row 1
1 source rowRow 1 · 2024-03-29 · Grant · Acquired 2,945 · Balance 225,279 F1: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed May 28, 2026 21:07 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 15,842 | $15.78 | $249,986.76 |
DisclosureSEC source: 0001860742-26-000080 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,260 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. Read SEC document |
| April 30, 2026 Filed May 1, 2026 20:16 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,611 | $15.90 | $25,614.90 |
DisclosureSEC source: 0001860742-26-000066 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,418 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:16 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 4,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000021 · form4.xml · nonDerivative · entry 2 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,807 F1 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances). Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:16 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | PurchaseCommon Shares, No Par Value | 4,400 | $17.90 | $78,760.00 |
DisclosureSEC source: 0001860742-26-000021 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,407 Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:11 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,451 | $17.65 | $25,610.15 |
DisclosureSEC source: 0001860742-26-000017 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,007 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:42 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,642 | $15.60 | $25,615.20 |
DisclosureSEC source: 0001860742-25-000032 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,556 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:09 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015805 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,914 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:02 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 2,210 | $11.59 | $25,613.90 |
DisclosureSEC source: 0001127602-25-013332 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,576 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 23:14 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,328 | $19.29 | $25,617.12 |
DisclosureSEC source: 0001127602-24-024770 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,694 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:05 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021759 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,366 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:35 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,764 | $14.52 | $25,613.28 |
DisclosureSEC source: 0001127602-24-019936 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,670 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 29, 2024 Filed Apr 1, 2024 20:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 2,945 | $10.61 | $31,246.45 |
DisclosureSEC source: 0001127602-24-011592 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,279 F1 · price: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:09 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,481 | $17.30 | $25,621.30 |
DisclosureSEC source: 0001127602-24-011820 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,906 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 3,896 | $8.02 | $31,245.92 |
DisclosureSEC source: 0001127602-24-000131 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,334 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:44 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,502 | $17.06 | $25,624.12 |
DisclosureSEC source: 0001127602-24-000493 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,425 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 20:28 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 3,801 | $8.22 | $31,244.22 |
DisclosureSEC source: 0001127602-23-025005 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,438 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 21:18 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,511 | $16.95 | $25,611.45 |
DisclosureSEC source: 0001127602-23-025316 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,923 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:01 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 3,906 | $8.00 | $31,248.00 |
DisclosureSEC source: 0001127602-23-019985 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,637 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:12 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,276 | $20.07 | $25,609.32 |
DisclosureSEC source: 0001127602-23-020015 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,412 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| May 19, 2023 Filed May 19, 2023 20:20 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 29,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016296 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,731 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:31 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014709 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,136 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 20:51 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | Tax withholdingCommon Shares, No Par Value | 6,692 | $17.12 | $114,567.04 |
DisclosureSEC source: 0001127602-23-013574 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,279 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 22:06 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,110 | $8.10 | $33,291.00 |
DisclosureSEC source: 0001127602-23-012412 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,526 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:26 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,471 | $17.41 | $25,610.11 |
DisclosureSEC source: 0001127602-23-012218 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,971 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:02 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 5,473 | $6.28 | $34,370.44 |
DisclosureSEC source: 0001127602-23-000166 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,416 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 21:15 UTC Amendment | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,989 | $6.89 | $34,374.21 |
DisclosureSEC source: 0001127602-22-023286 · form4a.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,943 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. F2 · shares: This Amended Form 4 is being filed to correct the number of RSUs acquired on September 30, 2022 as reported on the Form 4 filed on October 3, 2022. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:47 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 5,533 | $6.89 | $38,122.37 |
DisclosureSEC source: 0001127602-22-023268 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,487 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:04 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,560 | $8.36 | $38,121.60 |
DisclosureSEC source: 0001127602-22-018807 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,200 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 6, 2022 20:16 UTC Amendment | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,314 | $8.36 | $36,065.04 |
DisclosureSEC source: 0001127602-22-018930 · form4a.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,954 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. F2 · shares: This Amended Form 4 is being filed to correct the number of RSUs acquired on June 30, 2022 as reported on the Form 4 filed on July 5, 2022. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:47 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018207 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,640 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| May 10, 2022 Filed May 12, 2022 23:37 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017853 · doc4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). F2 · shares: The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:08 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,668 | $22.85 | $38,113.80 |
DisclosureSEC source: 0001127602-22-011300 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,253 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:14 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,380 | $27.61 | $38,101.80 |
DisclosureSEC source: 0001127602-22-000097 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,585 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:47 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,368 | $27.85 | $38,098.80 |
DisclosureSEC source: 0001127602-21-026457 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,205 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:15 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,300 | $29.32 | $38,116.00 |
DisclosureSEC source: 0001127602-21-021231 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,837 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:13 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014914 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,537 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,188 | $31.74 | $37,707.12 |
DisclosureSEC source: 0001127602-21-012766 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,892 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 23:58 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,802 | $20.80 | $37,481.60 |
DisclosureSEC source: 0001127602-21-000249 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,704 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:03 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 2,413 | $15.54 | $37,498.02 |
DisclosureSEC source: 0001127602-20-026311 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,902 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:35 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 2,050 | $18.29 | $37,494.50 |
DisclosureSEC source: 0001127602-20-020927 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,489 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 01, 2020 Filed May 1, 2020 20:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 11,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015039 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,439 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $200,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 2,419 | $15.50 | $37,494.50 |
DisclosureSEC source: 0001127602-20-012712 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,402 Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 21:47 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,253 | $29.92 | $37,489.76 |
DisclosureSEC source: 0001127602-20-000196 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,983 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:41 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,716 | $21.85 | $37,494.60 |
DisclosureSEC source: 0001127602-19-029782 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,730 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:15 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,486 | $25.22 | $37,476.92 |
DisclosureSEC source: 0001127602-19-023539 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,014 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017268 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,528 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| March 29, 2019 Filed Apr 3, 2019 21:04 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,518 | $24.70 | $37,494.60 |
DisclosureSEC source: 0001127602-19-014685 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,895 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:31 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 2,210 | $18.47 | $40,818.70 |
DisclosureSEC source: 0001127602-19-000712 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,377 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 20:37 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,460 | $25.67 | $37,478.20 |
DisclosureSEC source: 0001127602-18-029069 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,167 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:36 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 1,613 | $23.24 | $37,486.12 |
DisclosureSEC source: 0001127602-18-022650 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,707 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.